What is the treatment for post-hypoxic myoclonus (Post-Hypoxic Action Myoclonus)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Treatment of post-hypoxic myoclonus should prioritize the use of propofol to suppress myoclonus, as it has been shown to be effective in this context 152. When considering treatment options for post-hypoxic myoclonus, it is essential to note that myoclonus can be particularly difficult to treat, with phenytoin often being ineffective [reference_id: 1]. The European Resuscitation Council and European Society of Intensive Care Medicine 2015 guidelines suggest using intermittent electroencephalography (EEG) to detect epileptic activity in patients with clinical seizure manifestations, including myoclonus [reference_id: 1]. Key points to consider in the treatment of post-hypoxic myoclonus include:

  • The use of antimyoclonic drugs such as clonazepam, sodium valproate, and levetiracetam, which may be effective in post-anoxic myoclonus [reference_id: 1]
  • The potential for seizures, including myoclonus, to increase the cerebral metabolic rate and exacerbate brain injury caused by cardiac arrest [reference_id: 1]
  • The importance of excluding potential precipitating causes, such as intracranial hemorrhage or electrolyte imbalance, before starting maintenance therapy [reference_id: 1]
  • The need for prolonged observation after treatment of seizures, as myoclonus and electrographic seizure activity are related to a poor prognosis, but individual patients may survive with a good outcome [reference_id: 1].

From the FDA Drug Label

The FDA drug label does not answer the question.

From the Research

Treatment Options for Post-Hypoxic Myoclonus

  • Anecdotal treatment with benzodiazepines and anaesthetics has been tried for myoclonic status epilepticus (MSE) 2
  • Valproic acid, clonazepam, and levetiracetam have shown to control epilepsy associated with Lance-Adams syndrome (LAS) effectively, either in combination with other drugs or alone 2
  • Levetiracetam is especially useful for posthypoxic myoclonus 3
  • A combination of medications is often needed to obtain adequate control of symptoms 3
  • Botulinum toxin is also being introduced for focal myoclonus with encouraging results 3
  • Deep brain stimulation is a novel and promising advance in LAS treatment 2
  • Perampanel may be an effective alternative for the treatment of myoclonias in patients with chronic post-hypoxic myoclonus 4

Medications Used for Post-Hypoxic Myoclonus

  • Levetiracetam: suggested as first-line treatment for cortical myoclonus 5
  • Valproic acid: commonly used for cortical myoclonus and demonstrated efficacy in epileptic syndromes 5
  • Clonazepam: used for subcortical-nonsegmental myoclonus and segmental myoclonus 5
  • Gamma-hydroxybutyric acid: used for alcohol-sensitive myoclonus 3
  • Perampanel: may be an effective alternative for the treatment of myoclonias in patients with chronic post-hypoxic myoclonus 4

Treatment Approach

  • A thorough evaluation for the myoclonus etiology is critical for developing a treatment strategy 5
  • Clinical neurophysiology, as assessed by electromyography and electroencephalography, can be used to classify the pathophysiology of the myoclonus 5
  • The treatment strategy for the myoclonus is best derived from the neurophysiology classification scheme categories 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Myoclonus.

Current opinion in neurology, 2003

Research

Treatment of myoclonus.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.